Omaxe Reports Narrowing Losses in Q2 FY26 Amid Ongoing Challenges
Omaxe Limited reported a consolidated net loss of Rs 166.42 crore for Q2 FY26, an improvement from Rs 239.48 crore loss in Q2 FY25. Total income decreased to Rs 298.03 crore from Rs 644.39 crore year-over-year. For H1 FY26, total income was Rs 644.39 crore with a net loss of Rs 352.19 crore. The company faces ongoing regulatory challenges, including an appeal with SAT against a SEBI order and income tax demands. Omaxe's consolidated balance sheet showed total assets of Rs 15,727.82 crore as of September 30, 2025.

*this image is generated using AI for illustrative purposes only.
Omaxe Limited , a prominent real estate company, has reported a consolidated net loss of Rs 166.42 crore for the second quarter of fiscal year 2026, showing an improvement from the Rs 239.48 crore loss recorded in the same quarter of the previous year. The company's financial performance, while still in the red, demonstrates some resilience in a challenging market environment.
Financial Highlights
For Q2 FY26, Omaxe's total income declined to Rs 298.03 crore from Rs 644.39 crore in Q2 FY25, reflecting a significant reduction in revenue. Despite the lower income, the company managed to narrow its losses, indicating potential cost-cutting measures or improved operational efficiencies.
| Particulars (in Rs Crore) | Q2 FY26 | Q2 FY25 | H1 FY26 | H1 FY25 |
|---|---|---|---|---|
| Total Income | 298.03 | 398.32 | 644.39 | 783.55 |
| Net Loss | 166.42 | 239.48 | 352.19 | 386.46 |
| Basic Earnings Per Share | (9.11) | (13.10) | (19.27) | (21.16) |
Half-Year Performance
For the first half of FY26, Omaxe reported a total income of Rs 644.39 crore, down from Rs 783.55 crore in the corresponding period of the previous year. The net loss for H1 FY26 stood at Rs 352.19 crore, showing an improvement from the Rs 386.46 crore loss in H1 FY25.
Regulatory Challenges
Omaxe continues to face regulatory challenges. The company has an ongoing appeal with the Securities Appellate Tribunal (SAT) against a SEBI order dated July 30, 2024. The SAT has granted a stay on certain directions of the SEBI order, with the next hearing scheduled for January 5, 2026.
Additionally, Omaxe and some of its subsidiaries are dealing with income tax demands for assessment years 2014-15 to 2022-23. The company has filed appeals before the appellate authority (CIT-A) and writ petitions challenging the reopening of cases. Management believes these orders will be dismissed in due course.
Financial Position
As of September 30, 2025, Omaxe's consolidated balance sheet showed total assets of Rs 15,727.82 crore. The company's equity share capital remained unchanged at Rs 182.90 crore, while other equity stood at negative Rs 739.92 crore, indicating accumulated losses.
Cash Flow and Liquidity
The company's cash flow statement revealed a net increase in cash and cash equivalents of Rs 329.32 crore for the half-year ended September 30, 2025. This improvement in liquidity may provide some financial flexibility to the company in the near term.
Outlook
Omaxe's ability to further reduce losses and return to profitability will likely depend on market conditions in the real estate sector, the resolution of regulatory issues, and the company's success in managing its operational costs and debt. Investors and stakeholders will be watching closely to see if the company can build on this marginal improvement in the coming quarters.
The real estate sector in India continues to face headwinds, and Omaxe's performance reflects these broader market challenges. As the company navigates through these difficult times, its focus on financial prudence and resolving regulatory matters will be crucial for its long-term sustainability and growth prospects.
Historical Stock Returns for Omaxe
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.22% | -3.73% | -5.80% | -2.06% | -29.93% | +11.57% |







































